Estimation of Functional Liver Reserve in Patients With Hepatocellular Carcinoma in Cirrhosis: the Value of Preoperative Cholinesterases
N/A
18 Years
90 Years
18 Years
90 Years
Not Enrolling
Both
Hepatocellular Carcinoma, Cirrhosis, Liver Neoplasm, Liver Disease
Both
Hepatocellular Carcinoma, Cirrhosis, Liver Neoplasm, Liver Disease
Trial Information
Estimation of Functional Liver Reserve in Patients With Hepatocellular Carcinoma in Cirrhosis: the Value of Preoperative Cholinesterases
Inclusion Criteria:
1. Total bilirubin < 2 mg/dl
2. No ascites
3. No esophageal varices, or esophageal varices eradicated by endoscopy
4. Liver volume:
- residual liver volume > or = 40% if total bilirubin < 1 mg/dl
- residual liver volume > or = 50% if total bilirubin between 1 and 1.5 mg/dl
- only limited resection if total bilirubin > 1.5 mg/dl
5. Portal vein embolization was selected in any case in whom RLV did not fit the
previous requirements.
Exclusion Criteria:
1. Total bilirubin > 2 mg/dl
2. Refractory ascites
3. Esophageal varices
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Outcome Measure:
The primary outcome was to investigate the value of preoperative cholinesterases in predict postoperative adverse outcome after hepatic resection for hepatocellular carcinoma in cirrhosis.
Safety Issue:
No
Authority:
Italy: Ministry of Health
Study ID:
CHE-HCC
NCT ID:
NCT00883454
Start Date:
Completion Date:
Related Keywords:
- Hepatocellular Carcinoma
- Cirrhosis
- Liver Neoplasm
- Liver Disease
- hepatocellular carcinoma
- liver tumor
- cirrhosis
- liver resection
- tumor staging
- liver disease staging
- Neoplasms
- Carcinoma
- Liver Cirrhosis
- Fibrosis
- Liver Diseases
- Liver Neoplasms
- Carcinoma, Hepatocellular
Name | Location |
|---|
